Parke-Davis Pharmaceutical Research, et al.; Withdrawal of Approval of 31 Abbreviated New Drug Applications

الملخص

The Food and Drug Administration (FDA) is withdrawing approval of 31 abbreviated new drug applications (ANDA's). The holders of the ANDA's notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn EFFECTIVE DATE: May 23, 1994.